CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Anyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06957054
NCT06957054N/ACompleted
CompareCT.gov

Assessment of Neural Biomarkers in Adult Subjects With Fragile X Syndrome and Typically Developing Subjects

Connecta Therapeutics, S.L.·observational·Posted May 4, 2025·Updated May 4, 2025

In Brief

An observational study evaluating Any for Fragile X Syndrome (FXS) and Neurotypical Adults. Completed, enrolled 20 participants across 2 sites.

Detailed Summary

The purpose of this non-interventional test /re-test study is to assess neural biomarkers in adult subjects with Fragile X syndrome compared to those measured in a population of typically developing adults

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsFragile X Syndrome (FXS), Neurotypical Adults
CountriesSpain
CollaboratorsHospital del Mar Research Institute (IMIM), Corporacion Parc Tauli, Ministry of Science and Innovation, Spain

Timeline

N/ACompletedFinished
20252026
First PostedMay 4, 2025
Enrollment StartDec 16, 2024
Primary CompletionMar 20, 2025
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 1.2 years ago

Interventions

Anyother

Any